Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent great progress! With your previous support and funding, the drug indicated for the potential treatment…...
Managing Stress as a Cancer Patient and Survivor
Has cancer affected your life and left you feeling not quite yourself? You’re not alone. Research shows that anxiety and distress are more common in people affected by cancer than in their healthy peers with no history of cancer. Cancer patients and survivors often have fears related to their health, such as…...
AFCR Congratulates Professor Nancy Ip for Being Appointed as the President of The Hong Kong University of Science and Technology (HKUST)
The Asian Fund for Cancer Research Limited congratulates world-renowned neuroscientist, Nancy Ip, Ph.D., the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST) on her appointment as its President-Elect beginning October 2022. Prof. Ip…...
Announcement: Chimera Bioengineering is the 2021 BRACE Award Venture Competition Winner
CONTACTS:Asian Fund for Cancer ResearchBradley Gillenwater, Senior Director for Corporate EngagementE-mail: [email protected] Chimera BioengineeringVlad Hogenhuis, M.D., CEOE-mail: [email protected] Little Dog CommunicationsJessica Yingling, Ph.D., PresidentE-mail: [email protected] / Phone: 1-858-344-8091 Asian Fund for Cancer Research Announces Chimera Bioengineering as the2021 BRACE Award Venture Competition Winner HONG KONG – Chimera Bioengineering has been…...